Open to opportunities

Olivier Morteau

@oliviermorteau

Scientific communications leader translating clinical data into compliant global publication strategies across neuroscience and rare disease.

United States

Message

What I'm looking for

I’m looking to lead compliant, data-driven scientific publication strategy across launch and lifecycle—partnering with Medical Affairs, HEOR, and market access, strengthening governance and agency delivery, and elevating congress and field medical impact.

I’m a strategic scientific communications leader with 12+ years in the pharmaceutical industry and a decade of bench research across neuroscience, immunology, rare disease, and specialty care. I build and scale high-performing global publication functions, shaping scientific platforms and driving compliant communication strategies grounded in data-driven insights.

I translate complex clinical data into cohesive publication strategies that align Medical Affairs, Clinical Development, HEOR, and Market Access. I’m known for leading cross-functional governance forums, managing global agency partners, and strengthening publication excellence frameworks with measurable impact across congress strategy, payer engagement, and field medical enablement.

In recent leadership roles, I’ve owned US medical communications and publications for neuroscience and led rare disease coverage on an interim basis. I developed and executed publication strategies supporting lifecycle management and launch readiness, spearheaded congress scientific strategy, and designed proactive/reactive field tools and training to improve MSL impact and consistency.

I’ve also served as a global scientific communications lead for rare disease programs, where I improved publication policy and metrics and trained affiliates on global publication processes. I’m a trusted partner to KOLs and executive stakeholders, with a strong ethics and compliance mindset, fluent French, and a commitment to scientific rigor and clear, accurate storytelling.

Experience

Work history, roles, and key accomplishments

Associate Director, Sci Comms

Vera Therapeutics

Sep 2025 - Feb 2026 (5 months)

Co-led the medical publication strategy for atacicept in IgA nephropathy, aligning data dissemination with clinical and launch-stage priorities. Directed development of eight peer-reviewed review articles and a disease-focused journal supplement, and strengthened the publication platform, governance cadence, and field medical training.

GPP Compliant Publication Development Congress And Supplement Execution Training

Director, Scientific Communications

Ipsen Bioscience

Jul 2023 - May 2025 (1 year 10 months)

Led US medical communications and publications for neuroscience and served ad interim for rare disease, supporting lifecycle management and launch readiness for DYSPORT, IQIRVO, and BILVAY. Spearheaded congress scientific strategy and developed proactive/reactive field medical tools and training to improve consistency and KOL engagement.

Neuroscience And Rare Disease Communication Lifecycle Management HEOR And Payer Value Narratives Field Medical Agency Management Publication Budgeting And Timeline Management

Associate Director, Publications

Alexion AstraZeneca Rare Diseases

Sep 2019 - Jul 2023 (3 years 10 months)

Global scientific communications lead for NMOSD, developing and implementing publication strategies for SOLIRIS (post-marketing) and ULTOMIRIS (launch stage). Led publication excellence improvements, updated the ULTOMIRIS communications platform, performed literature gap analyses, and developed KOL symposia and forum talks for international conferences.

Publication Excellence Frameworks Scientific Communications Platform Updates Publication Policy And SOP Training

Associate Director, Scientific Comms

MedDay Pharmaceuticals

Aug 2017 - May 2019 (1 year 9 months)

Built the scientific communications team and created processes for MedDay-sponsored nonclinical and clinical publications. Developed the Phase III communications strategy for the main product in preparation for launch, managed medical information requests, and co-developed biannual early access program reports.

Scientific Communications Nonclinical And Clinical Publication Processes Scientific Publication Strategy

Senior Manager, Medical Communications

Tesaro

Jan 2015 - Jul 2017 (2 years 6 months)

Built and led TESARO’s global publications team, supervising two publication managers, and developed launch publication strategies for VARUBI and ZEJULA. Planned early- and late-stage publication portfolios, co-developed MSL training materials, and supported advisory board planning and execution.

Publication Planning MSL Core Data Decks Cross Functional Stakeholder Management

Medical Publication Manager

EMD Serono

Feb 2013 - Jan 2015 (1 year 11 months)

Drove development and implementation of global strategic publication plans across endocrinology and metabolic care, ensuring timely, ethical, and compliant deliverables. Chaired monthly publication steering committees and managed end-to-end creation and review of manuscripts, abstracts, posters, and oral presentations from globally sponsored and investigator-initiated trials.

Publication Planning CRO Management Stakeholder And KOL Education

Medical Writer

Lumleian

Jan 2012 - Feb 2013 (1 year 1 month)

Prepared oncology and immune-disorder disease state primer reports covering disease overview, standard of care, safety/efficacy summaries, and regulatory status. Conducted research synthesis using standardized templates and trained a new intern writer while optimizing KOL R&D portfolio strategy discussions.

Disease State Primer Writing Critical Appraisal Oncology And Immunology Communication Regulatory Status Summarization R&D Portfolio Support For KOLs Training And Supervision

Medical Writer, Medical Affairs

Vertex Pharmaceuticals

Jun 2011 - Nov 2011 (5 months)

Implemented medical and scientific communications strategy for the HCV franchise, managing production, review, and submission of 19 clinical abstracts for two international conferences within two-week deadlines. Drafted and edited clinical development overviews for INCIVEK (telaprevir) and supported conference poster/slide deck design and review for timely publication submissions.

HCV Medical Communications Rapid Turnaround Manuscript Production Review And Submission Management Communication Strategy